Jihong Liu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Anlotinib and Niraparib Dual Therapy Evaluation in Platinum-resistant Recurrent Ovarian Cancer (NCT04376073) | Jihong Liu | 2020-05-22 |
Track Jihong Liu automatically
Every clearance here is in the API, with alerts when new ones post.